GRP78 is Overexpressed in Non-small Cell Lung Cancer Tissues and is Associated with High VEGF Expression in Squamous Cell Carcinoma: A Pilot Study

Autor: Maha S. Al-Keilani, Mohammad A. Alqudah, Basima A. Almomani, Moath M. Alrjoub, Batool A. Shhabat, Karem H. Alzoubi

Publikováno v: Current Cancer Drug Targets. 23

Background: Neovascularization is essential for the growth and progression of tumor tissues. GRP78 is frequently overexpressed in various cancers and has been suggested as a proangiogenic factor. Purpose: This study aimed to investigate the expressio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ee90f37594799942fba217984aaca4ab
https://doi.org/10.2174/1568009623666230418111020

Immunohistochemical expression of GRP78 in relation to angiogenesis markers VEGF-a and CD31 and other histopathological parameters in NSCLC

Autor: Basima A. Almomani, Maha S. Al-Keilani, Batool A. Shhabat, Mohammad Alqudah, Hiba Alzoubi, Moath M. Alrjoub

Publikováno v: Journal of Clinical Oncology. 37:e20500-e20500

e20500 Background: Neovascularization is essential for the growth and progression of tumor tissues. GRP78 is frequently overexpressed in various types of cancers and has been suggested as a proangiogenic factor. Methods: In order to evaluate GRP78 ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::29c04c8657d50f01b1d797a0c46dd956
https://doi.org/10.1200/jco.2019.37.15_suppl.e20500

FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma.

Autor: Al Shboul S; Department of Pharmacology and Public Health, Faculty of Medicine, The Hashemite University, Zarqa, 13133, Jordan. sofian@hu.edu.jo., Boyle S; MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Crewe Road, Edinburgh, EH4 2XU, UK., Singh A; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XR, Scotland, UK., Saleh T; Department of Pharmacology and Public Health, Faculty of Medicine, The Hashemite University, Zarqa, 13133, Jordan., Alrjoub M; Department of Pathology and Microbiology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan., Abu Al Karsaneh O; Department of Microbiology, Pathology, and Forensic Medicine, Faculty of Medicine, The Hashemite University, Zarqa, 13133, Jordan., Mryyian A; Department of Pharmacology and Public Health, Faculty of Medicine, The Hashemite University, Zarqa, 13133, Jordan., Dawoud R; Department of Pharmacology and Public Health, Faculty of Medicine, The Hashemite University, Zarqa, 13133, Jordan., Gul S; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XR, Scotland, UK., Abu Baker S; Department of Pathology and Microbiology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan., Ball K; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XR, Scotland, UK., Hupp T; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XR, Scotland, UK. ted.hupp@ed.ac.uk., Brennan PM; Translational Neurosurgery, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. paul.brennan@ed.ac.uk.; Translational Neurosurgery, Department of Clinical Neurosciences, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SB, Scotland, UK. paul.brennan@ed.ac.uk.

Publikováno v: Brain tumor pathology [Brain Tumor Pathol] 2024 Jan; Vol. 41 (1), pp. 4-17. Date of Electronic Publication: 2023 Dec 14.